After adjusting for number of lines of prior therapy, sex, age, and immunotherapy regimen, PNR was found to have significant association with PFS in R/R cHL patients treated with anti‐PD‐1‐based therapy (Figure 2E). Here, PDCD1 is linked to classic Hodgkin lymphoma.